pentobarbital will lessen the level or result of elbasvir/grazoprevir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic outcome of elbasvir/grazoprevir may be diminished if coadministered with potent CYP3A inducers and it is consequently contraindicated.Pure start with no medication and birth using an epid